Bayesian Capital Management’s VeriSign VRSN Stock Holding History

Bayesian Capital Management’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,600	Closed	-$602K	–	1038
2022 Q2	$602K	Sell	3,600 -1,896	-34%	-$348K	0.11%	278
2022 Q1	$1.22M	Buy	+5,496	New	+$1.2M	0.18%	164
2020 Q2	–	Sell	-2,758	Closed	-$497K	–	810
2020 Q1	$497K	Buy	+2,758	New	+$542K	0.11%	297
2019 Q3	–	Sell	-2,072	Closed	-$433K	–	705
2019 Q2	$433K	Buy	+2,072	New	+$407K	0.09%	290
2019 Q1	–	Sell	-2,800	Closed	-$415K	–	775
2018 Q4	$415K	Buy	+2,800	New	+$420K	0.09%	326
2018 Q2	–	Sell	-3,027	Closed	-$359K	–	747
2018 Q1	$359K	Buy	+3,027	New	+$351K	0.09%	355
2017 Q3	–	Sell	-3,600	Closed	-$335K	–	656
2017 Q2	$335K	Buy	+3,600	New	+$325K	0.12%	259
2017 Q1	–	Sell	-18,800	Closed	-$1.43M	–	707
2016 Q4	$1.43M	Buy	+18,800	New	+$1.49M	0.36%	68
2016 Q3	–	Sell	-3,695	Closed	-$319K	–	522
2016 Q2	$319K	Buy	+3,695	New	+$319K	0.19%	220

Other funds holding VRSN

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Cantillon Capital Management New York $665M AUM 25.91% 1-Year Est. Return

Bayesian Capital Management's VRSN Position: Q3 2022 in Review

Bayesian Capital Management sold out of VeriSign (VRSN) in Q3 2022, closing a stake of 3,600 shares — an estimated $602K sold.

Bayesian Capital Management first reported a position in VRSN in Q2 2016 and held it in 9 quarters. The position peaked at $1.43M in Q4 2016. 566 funds tracked by Wall St. Rank hold VRSN as of Q3 2022.

Bayesian Capital Management reported no remaining VeriSign position as of Q3 2022 after selling out during the quarter.
Bayesian Capital Management sold 3,600 VeriSign shares in Q3 2022, an estimated $602K.
Bayesian Capital Management first reported a position in VeriSign in Q2 2016 and held it in 9 quarters.
Bayesian Capital Management's VeriSign position peaked at $1.43M in Q4 2016.
566 funds tracked by Wall St. Rank held VeriSign as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.